Teknova to participate in upcoming investor conference

Hollister, calif., aug. 31, 2022 (globe newswire) -- alpha teknova, inc. (“teknova”) (nasdaq: tkno), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the company will participate in the following upcoming investor conference.

TKNO Ratings Summary

TKNO Quant Ranking